共 324 条
[1]
Denton CP(2017)Systemic sclerosis Lancet. 390 1685-1699
[2]
Khanna D(2010)Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database Ann Rheum Dis. 69 1809-1815
[3]
Tyndall AJ(2008)Diagnosis, management and prevention of scleroderma renal disease Curr Opin Rheumatol. 20 692-696
[4]
Bannert B(2012)Scleroderma renal crisis: a retrospective multicentre study on 91 patients and 427 controls Rheumatology (Oxford). 51 460-467
[5]
Vonk M(2007)Scleroderma renal crisis: patient characteristics and long-term outcomes QJM. 100 485-494
[6]
Airò P(2020)Analysis of anti-RNA polymerase III antibody-positive systemic sclerosis and altered GPATCH2L and CTNND2 expression in scleroderma renal crisis J Rheumatol. 47 1668-1677
[7]
Cozzi F(1990)Outcome of renal crisis in systemic sclerosis: relation to availability of angiotensin converting enzyme (ACE) inhibitors Ann Intern Med. 113 352-357
[8]
Carreira PE(2021)Exploring molecular pathology of chronic kidney disease in systemic sclerosis by analysis of urinary and serum proteins Rheumatol Adv Pract 5 rkaa083-1208
[9]
Bancel DF(2021)Renal dysfunction in systemic sclerosis beyond scleroderma renal crisis Rheumatol Int. 41 1203-222
[10]
Allanore Y(2021)Estimated glomerular filtration rate is a marker of mortality in the European Scleroderma Trials and Research Group (EUSTAR) database Rheumatology (Oxford). 61 213-89